Trial Profile
A Phase 3, Double-blind, Randomized Study of the Safety, Tolerability, and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2019
Price :
$35
*
At a glance
- Drugs Ketorolac (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors American Regent; Luitpold Pharmaceuticals
- 05 May 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 05 May 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 05 Nov 2010 New trial record.